@simile_ai

We’re building a future where people make better decisions today, by simulating how people will think, decide, and behave before ideas meet the real world. Read more about what we're building in today's @nytimes. Thank you, @srimuppidi. https://t.co/kiIfpDdKEk

Today we’re announcing our Series B. We’ve raised $200M at a $2B valuation from Greenoaks with participation from Index Ventures, Hanabi, A*, Bain Capital Ventures, CVS Health Ventures, and Definition. Our mission is to simulate all eight billion people on earth, accurately. https://t.co/Pkumac7fI2

Our work on generative agents showed that it's possible to accurately simulate human behavior by capturing rich information about real people. @joon_s_pk spoke with @Nature about how our work builds on this research, and how enterprises can now use simulations to test decisions before they hit the real world: https://t.co/5XswZaafif

Simile is increasing decision-making capacity and decreasing research time. We are proud to work with partners like @CVSHealth! 🤝 Projects that took months are now taking hours, and studies are closer resembling human behavior than prior self-reported research - all with the goal of providing the best products and services for customers at companies like CVS Health, where the customer is centered in every decision.   Read more in the CVS Health whitepaper below.

Happy Valentine’s Day from Team Simile! Fun fact: In our founders’ 2023 paper, @joon_s_pk and team introduced the concept of generative agents to the world by simulating a town of 25 agents… one of who was planning a Valentine’s Day party. The agents autonomously spread invitations to the party over the next two days, made new acquaintances, and asked each other out on dates to the party. This town of agents, Smallville, along with all the flirty festivities, was instrumental in creating the field of AI-based simulation. Love is in the air! 🎈